Efficacy And Safety Of Simtuzumab For The Treatment Of Nonalcoholic Steatohepatitis With Bridging Fibrosis Or Cirrhosis: Results Of Two Phase 2b, Dose-Ranging, Randomized, Placebo-Controlled Trials

JOURNAL OF HEPATOLOGY(2017)

引用 22|浏览15
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要